BALSALAZIDE DISODIUM

BALSALAZIDE DISODIUM was reported 519 times

BALSALAZIDE DISODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPERSTHENURIA 1 0.1000
1 MESENTERIC VENOUS OCCLUSION 1 0.0417
2 METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY 1 0.0357
3 APHAKIA 1 0.0213
4 PERINATAL STROKE 1 0.0196
5 GLOMERULAR FILTRATION RATE 1 0.0137
6 BUNDLE BRANCH BLOCK BILATERAL 1 0.0104
7 CERVICAL DILATATION 1 0.0100
8 BLOOD CHOLESTEROL 4 0.0084
9 CHORDEE 1 0.0071
10 PRIMARY HYPERALDOSTERONISM 1 0.0064
11 BIFASCICULAR BLOCK 1 0.0053
12 EFFUSION 7 0.0051
13 GINGIVAL OPERATION 1 0.0045
14 PERFORATED ULCER 3 0.0040
15 ERYTHEMA INFECTIOSUM 1 0.0039
16 SCROTAL PAIN 2 0.0037
17 APPLICATION SITE MASS 1 0.0036
18 COLON DYSPLASIA 1 0.0035
19 SUBCUTANEOUS NODULE 1 0.0035
20 RETINAL DEPIGMENTATION 1 0.0033
21 MILIA 1 0.0028
22 HEPATOSPLENIC T-CELL LYMPHOMA 1 0.0027
23 GENITAL ABSCESS 1 0.0025
24 SKIN NODULE 1 0.0025
25 PLEUROPERICARDITIS 1 0.0024
26 CORONA VIRUS INFECTION 1 0.0023
27 BLOOD HOMOCYSTEINE INCREASED 1 0.0023
28 SPLENIC HAEMORRHAGE 1 0.0020
29 EOSINOPHILIC PNEUMONIA 6 0.0019
30 INTRAOCULAR PRESSURE DECREASED 1 0.0019
31 EXPULSION OF MEDICATION 1 0.0019
32 ANAL STENOSIS 1 0.0019
33 URETHRITIS 1 0.0018
34 PROCTITIS ULCERATIVE 1 0.0017
35 LOWER EXTREMITY MASS 1 0.0016
36 MALIGNANT MELANOMA IN SITU 2 0.0016
37 BLOOD CORTISOL DECREASED 1 0.0016
38 OEDEMA GENITAL 1 0.0016
39 NEUROPATHIC ARTHROPATHY 1 0.0015
40 POSTOPERATIVE ABSCESS 1 0.0015
41 CONGESTIVE CARDIOMYOPATHY 6 0.0014
42 FOREARM FRACTURE 1 0.0014
43 ECHOCARDIOGRAM ABNORMAL 2 0.0014
44 SCROTAL OEDEMA 1 0.0014
45 VENOUS INSUFFICIENCY 1 0.0014
46 GLOMERULONEPHRITIS MINIMAL LESION 1 0.0014
47 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
48 MICROALBUMINURIA 1 0.0013
49 DRUG TOLERANCE INCREASED 1 0.0013
50 CROUP INFECTIOUS 1 0.0013
51 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2 0.0013
52 HEPATITIS VIRAL 1 0.0012
53 POLYCYTHAEMIA VERA 1 0.0012
54 ACCIDENTAL NEEDLE STICK 1 0.0012
55 DYSCHROMATOPSIA 1 0.0012
56 SCROTAL SWELLING 1 0.0011
57 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
58 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
59 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
60 DROWNING 1 0.0010
61 URINARY BLADDER HAEMORRHAGE 2 0.0009
62 ENDOMETRIAL CANCER 2 0.0009
63 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
64 AORTIC DILATATION 1 0.0009
65 CROHN'S DISEASE 6 0.0009
66 SERONEGATIVE ARTHRITIS 1 0.0009
67 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
68 INFECTED CYST 1 0.0008
69 DERMAL CYST 2 0.0008
70 RECTAL TENESMUS 1 0.0008
71 GASTRIC ULCER PERFORATION 1 0.0008
72 ENDODONTIC PROCEDURE 2 0.0008
73 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
74 MEDICATION RESIDUE 2 0.0008
75 BILIARY OBSTRUCTION 1 0.0008
76 RETINAL DEGENERATION 1 0.0008
77 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
78 DIARRHOEA HAEMORRHAGIC 7 0.0007
79 EAR CONGESTION 2 0.0007
80 CARDIOVERSION 1 0.0007
81 COLITIS ULCERATIVE 32 0.0007
82 PERIODONTAL DISEASE 1 0.0007
83 INTESTINAL ULCER 1 0.0006
84 GASTRIC DILATATION 1 0.0006
85 SALMONELLOSIS 1 0.0006
86 ENTERITIS INFECTIOUS 1 0.0006
87 INJECTION SITE OEDEMA 1 0.0006
88 CERVICAL SPINAL STENOSIS 1 0.0006
89 INCORRECT STORAGE OF DRUG 1 0.0006
90 MACULOPATHY 2 0.0006
91 VOCAL CORD PARALYSIS 1 0.0006
92 HYPERTENSIVE HEART DISEASE 1 0.0005
93 BILE DUCT OBSTRUCTION 1 0.0005
94 OESOPHAGEAL ULCER 2 0.0005
95 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
96 MUSCLE RUPTURE 2 0.0005
97 UNDERWEIGHT 1 0.0005
98 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
99 HYPOSPADIAS 1 0.0005
100 BODY TEMPERATURE FLUCTUATION 1 0.0005
101 DEVICE CONNECTION ISSUE 1 0.0005
102 CARDIOMYOPATHY 7 0.0005
103 AORTIC VALVE INCOMPETENCE 2 0.0005
104 ANAEMIA MACROCYTIC 1 0.0005
105 ABSCESS INTESTINAL 1 0.0005
106 VITREOUS DETACHMENT 1 0.0005
107 FREQUENT BOWEL MOVEMENTS 12 0.0004
108 ABNORMAL LOSS OF WEIGHT 3 0.0004
109 PULSE ABNORMAL 1 0.0004
110 WRONG DOSE 1 0.0004
111 RASH VESICULAR 2 0.0004
112 CARTILAGE INJURY 1 0.0004
113 MUCOUS STOOLS 2 0.0004
114 INABILITY TO AFFORD MEDICATION 4 0.0004
115 HYPERPARATHYROIDISM SECONDARY 1 0.0004
116 URINARY TRACT INFECTION BACTERIAL 1 0.0004
117 TUBERCULIN TEST POSITIVE 1 0.0004
118 ILEOSTOMY 1 0.0004
119 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
120 GASTROINTESTINAL INFLAMMATION 3 0.0004
121 RADICULOPATHY 1 0.0004
122 RENAL CYST 3 0.0004
123 YAWNING 1 0.0004
124 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
125 WEIGHT BEARING DIFFICULTY 1 0.0004
126 BLOOD SODIUM INCREASED 1 0.0004
127 ABDOMINAL RIGIDITY 1 0.0004
128 APPLICATION SITE HAEMORRHAGE 1 0.0004
129 RENAL CANCER STAGE IV 1 0.0004
130 PLEURITIC PAIN 1 0.0004
131 RENAL TUBULAR DISORDER 1 0.0004
132 LIP PAIN 1 0.0003
133 VASCULAR GRAFT 1 0.0003
134 HYPERTONIC BLADDER 1 0.0003
135 EYELID MARGIN CRUSTING 1 0.0003
136 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
137 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
138 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
139 IRITIS 1 0.0003
140 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
141 RECTAL CANCER 1 0.0003
142 EYELIDS PRURITUS 1 0.0003
143 BLEPHAROSPASM 2 0.0003
144 LOOSE TOOTH 1 0.0003
145 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
146 NEAR DEATH EXPERIENCE 1 0.0003
147 NEPHROTIC SYNDROME 2 0.0003
148 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
149 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
150 PRODUCT ODOUR ABNORMAL 3 0.0003
151 DEFAECATION URGENCY 2 0.0003
152 ERYTHEMA NODOSUM 1 0.0003
153 HAND FRACTURE 2 0.0003
154 PRODUCT SUPPLY ISSUE 2 0.0003
155 PYODERMA GANGRENOSUM 1 0.0003
156 INJECTION SITE HAEMATOMA 4 0.0003
157 BLOOD PHOSPHORUS DECREASED 1 0.0003
158 FOOD INTOLERANCE 1 0.0003
159 GASTROINTESTINAL PAIN 3 0.0003
160 INJECTION SITE NODULE 3 0.0003
161 WOUND HAEMORRHAGE 1 0.0003
162 FREEZING PHENOMENON 1 0.0003
163 CARDIAC DYSFUNCTION 1 0.0003
164 BONE DENSITY ABNORMAL 1 0.0003
165 IMPULSIVE BEHAVIOUR 1 0.0003
166 MYOCARDITIS 3 0.0003
167 GASTRIC INFECTION 1 0.0003
168 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
169 BLOOD IRON DECREASED 3 0.0003
170 RESPIRATORY TRACT CONGESTION 4 0.0003
171 MACULAR DEGENERATION 3 0.0003
172 SKIN PAPILLOMA 1 0.0002
173 SPINAL FUSION SURGERY 1 0.0002
174 GOITRE 1 0.0002
175 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
176 SPINAL STENOSIS 1 0.0002
177 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 1 0.0002
178 COLITIS 9 0.0002
179 INJECTION SITE IRRITATION 3 0.0002
180 TONGUE DISCOMFORT 1 0.0002
181 LUNG NEOPLASM 1 0.0002
182 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
183 DYSPHEMIA 1 0.0002
184 GINGIVAL SWELLING 1 0.0002
185 RHINITIS ALLERGIC 1 0.0002
186 DRUG EFFECT DELAYED 1 0.0002
187 LUPUS-LIKE SYNDROME 2 0.0002
188 INJECTION SITE PAPULE 1 0.0002
189 ARTHRITIS INFECTIVE 1 0.0002
190 LACERATION 2 0.0002
191 CARDIAC TAMPONADE 1 0.0002
192 EYE INFLAMMATION 2 0.0002
193 SUBCUTANEOUS ABSCESS 1 0.0002
194 HUMERUS FRACTURE 1 0.0002
195 LIGAMENT SPRAIN 2 0.0002
196 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
197 FLUID INTAKE REDUCED 1 0.0002
198 TOXIC ENCEPHALOPATHY 1 0.0002
199 DRY THROAT 2 0.0002
200 TOOTH ABSCESS 2 0.0002
201 EYE DISCHARGE 2 0.0002
202 BASAL CELL CARCINOMA 3 0.0002
203 PARTIAL SEIZURES 1 0.0002
204 SENSITIVITY TO WEATHER CHANGE 1 0.0002
205 FOOD POISONING 1 0.0002
206 INTESTINAL RESECTION 1 0.0002
207 ANAL ABSCESS 1 0.0002
208 ERYTHEMA OF EYELID 1 0.0002
209 NONSPECIFIC REACTION 1 0.0002
210 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
211 MITRAL VALVE INCOMPETENCE 2 0.0002
212 NEUTROPHILIA 1 0.0002
213 INTERNAL HAEMORRHAGE 2 0.0002
214 CORONARY ARTERY BYPASS 1 0.0002
215 COLD SWEAT 3 0.0002
216 SINUS HEADACHE 1 0.0002
217 INJECTION SITE VESICLES 1 0.0002
218 HAEMATOCHEZIA 9 0.0002
219 SMALL INTESTINAL OBSTRUCTION 2 0.0002
220 INJECTION SITE EXTRAVASATION 2 0.0002
221 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
222 SCREAMING 1 0.0002
223 MYDRIASIS 2 0.0002
224 HAEMORRHOIDS 3 0.0002
225 NODULE 2 0.0002
226 PRODUCT PREPARATION ISSUE 1 0.0002
227 WALKING AID USER 1 0.0002
228 APPETITE DISORDER 1 0.0002
229 PREGNANCY 3 0.0001
230 MENINGITIS 1 0.0001
231 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
232 FULL BLOOD COUNT DECREASED 3 0.0001
233 SINUS CONGESTION 2 0.0001
234 RIB FRACTURE 3 0.0001
235 LYMPHOEDEMA 1 0.0001
236 PULMONARY HYPERTENSION 3 0.0001
237 SEASONAL ALLERGY 2 0.0001
238 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
239 DERMATITIS BULLOUS 1 0.0001
240 HYPOKINESIA 2 0.0001
241 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
242 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
243 SUNBURN 1 0.0001
244 RASH PAPULAR 3 0.0001
245 HYDRONEPHROSIS 1 0.0001
246 TROPONIN INCREASED 1 0.0001
247 AORTIC ANEURYSM 1 0.0001
248 HAEMODYNAMIC INSTABILITY 1 0.0001
249 INSURANCE ISSUE 2 0.0001
250 BOWEL MOVEMENT IRREGULARITY 1 0.0001
251 PROCEDURAL COMPLICATION 1 0.0001
252 RENAL FAILURE CHRONIC 1 0.0001
253 RASH PRURITIC 7 0.0001
254 APHTHOUS ULCER 1 0.0001
255 PELVIC FRACTURE 1 0.0001
256 MULTIPLE ALLERGIES 1 0.0001
257 INJECTION SITE PAIN 39 0.0001
258 PRODUCT USE COMPLAINT 2 0.0001
259 FURUNCLE 1 0.0001
260 BLOOD ALBUMIN DECREASED 1 0.0001
261 TRICUSPID VALVE INCOMPETENCE 1 0.0001
262 ABNORMAL FAECES 1 0.0001
263 HYPERAESTHESIA 1 0.0001
264 OSTEOPOROSIS 5 0.0001
265 INJECTION SITE PRURITUS 8 0.0001
266 INFUSION SITE ERYTHEMA 1 0.0001
267 RECTAL HAEMORRHAGE 5 0.0001
268 BLOOD MAGNESIUM DECREASED 1 0.0001
269 RASH MACULAR 4 0.0001
270 SPINAL OSTEOARTHRITIS 1 0.0001
271 LUNG INFILTRATION 1 0.0001
272 EAR INFECTION 3 0.0001
273 HAEMOLYTIC ANAEMIA 1 0.0001
274 ANAL INCONTINENCE 1 0.0001
275 OROPHARYNGEAL DISCOMFORT 1 0.0001
276 GASTROINTESTINAL CARCINOMA 1 0.0001
277 DRUG EFFECT INCOMPLETE 4 0.0001
278 RETINAL DETACHMENT 1 0.0001
279 PRODUCT DISTRIBUTION ISSUE 1 0.0001
280 APPENDICITIS 1 0.0001
281 FLANK PAIN 1 0.0001
282 PHOTOPHOBIA 2 0.0001
283 SQUAMOUS CELL CARCINOMA 1 0.0001
284 LEUKAEMIA 1 0.0001
285 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
286 RECALLED PRODUCT ADMINISTERED 1 0.0001
287 SINUS BRADYCARDIA 1 0.0001
288 INFLAMMATORY BOWEL DISEASE 1 0.0001
289 PHARYNGEAL SWELLING 1 0.0001
290 CARDIAC FAILURE 8 0.0001
291 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
292 DRUG LEVEL DECREASED 1 0.0001
293 SUBARACHNOID HAEMORRHAGE 1 0.0001
294 BODY TEMPERATURE INCREASED 2 0.0001
295 INJECTION SITE RASH 3 0.0001
296 CHEST DISCOMFORT 10 0.0001
297 EAR DISCOMFORT 1 0.0001
298 TEMPERATURE INTOLERANCE 1 0.0001
299 POOR VENOUS ACCESS 1 0.0001
300 JOINT DISLOCATION 1 0.0001
301 BODY HEIGHT DECREASED 1 0.0001
302 PRURITUS GENERALISED 2 0.0001
303 PRODUCT DISPENSING ERROR 2 0.0001
304 PULMONARY THROMBOSIS 1 0.0001
305 EYE DISORDER 3 0.0001
306 DENTAL CARIES 1 0.0001
307 FUNGAL INFECTION 3 0.0001
308 TOOTH DISORDER 2 0.0001
309 NERVE INJURY 1 0.0001
310 MALNUTRITION 1 0.0001
311 EYE PRURITUS 3 0.0001
312 FISTULA 1 0.0001
313 INJECTION SITE ERYTHEMA 11 0.0001
314 HEART RATE IRREGULAR 2 0.0001
315 PRODUCT AVAILABILITY ISSUE 2 0.0001
316 CHOLECYSTECTOMY 1 0.0001
317 PRODUCT SUBSTITUTION ISSUE 5 0.0001
318 DRY MOUTH 7 0.0001
319 EYELID OEDEMA 1 0.0001
320 CHOLECYSTITIS 1 0.0001
321 MOBILITY DECREASED 6 0.0001
322 WRIST FRACTURE 1 0.0001
323 PARAESTHESIA 13 0.0001
324 PLEURAL EFFUSION 5 0.0001
325 DYSURIA 3 0.0001
326 CARDIOMEGALY 1 0.0001
327 SPINAL OPERATION 1 0.0001
328 ABNORMAL WEIGHT GAIN 1 0.0001
329 CYST 1 0.0001
330 APPLICATION SITE IRRITATION 1 0.0001
331 AGEUSIA 2 0.0001
332 DERMATITIS ALLERGIC 1 0.0001
333 ABDOMINAL PAIN LOWER 2 0.0001
334 MUSCLE ATROPHY 1 0.0001
335 INCORRECT DOSE ADMINISTERED 18 0.0001
336 HYPOPHAGIA 2 0.0001
337 RHINORRHOEA 5 0.0001
338 HIATUS HERNIA 1 0.0001
339 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
340 GASTRITIS 2 0.0001
341 ORAL CANDIDIASIS 1 0.0001
342 PULMONARY CONGESTION 1 0.0001
343 HAIR TEXTURE ABNORMAL 1 0.0001
344 UVEITIS 1 0.0001
345 LIMB INJURY 2 0.0001
346 IMPAIRED GASTRIC EMPTYING 1 0.0001
347 GINGIVAL BLEEDING 1 0.0001
348 INFLUENZA LIKE ILLNESS 6 0.0001
349 APPLICATION SITE RASH 1 0.0001
350 CONTUSION 7 0.0001
351 INJECTION SITE REACTION 5 0.0001
352 ARTHRALGIA 30 0.0001
353 MEDICATION ERROR 4 0.0001
354 RHABDOMYOLYSIS 3 0.0001
355 APHONIA 1 0.0001
356 MASS 1 0.0001
357 BLOOD TEST ABNORMAL 1 0.0001
358 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
359 HEART RATE INCREASED 7 0.0001
360 FLATULENCE 4 0.0001
361 HERPES ZOSTER 4 0.0001
362 IMPAIRED QUALITY OF LIFE 1 0.0001
363 LETHARGY 4 0.0001
364 PARAESTHESIA ORAL 1 0.0001
365 NEEDLE ISSUE 2 0.0001
366 LABORATORY TEST ABNORMAL 2 0.0001
367 CATARACT 4 0.0001
368 PULMONARY MASS 1 0.0001
369 HAEMORRHAGE 7 0.0001
370 HAEMORRHAGE INTRACRANIAL 1 0.0001
371 DIARRHOEA 43 0.0001
372 BLOOD POTASSIUM DECREASED 2 0.0001
373 UNEVALUABLE EVENT 5 0.0001
374 BLOOD COUNT ABNORMAL 1 0.0001
375 OSTEOPENIA 1 0.0001
376 OEDEMA PERIPHERAL 8 0.0001
377 NEPHROLITHIASIS 3 0.0001
378 HIP ARTHROPLASTY 1 0.0001
379 OROPHARYNGEAL PAIN 6 0.0001
380 MUSCULOSKELETAL CHEST PAIN 1 0.0001
381 ABDOMINAL PAIN 15 0.0001
382 INSOMNIA 17 0.0001
383 HEAD INJURY 2 0.0001
384 DISEASE RECURRENCE 3 0.0001
385 PNEUMOTHORAX 1 0.0001
386 CYSTITIS 2 0.0001
387 HYPOTHYROIDISM 2 0.0001
388 IMPAIRED HEALING 2 0.0001
389 MULTIPLE FRACTURES 1 0.0001
390 MANIA 1 0.0001
391 VENTRICULAR TACHYCARDIA 1 0.0001
392 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
393 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
394 DRY EYE 3 0.0001
395 MUSCLE SPASMS 11 0.0001
396 SOMNOLENCE 12 0.0001
397 FLUSHING 6 0.0001
398 SINUSITIS 6 0.0001
399 ASTHENIA 22 0.0001
400 BALANCE DISORDER 5 0.0001
401 PAIN IN EXTREMITY 17 0.0001
402 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
403 ABDOMINAL DISTENSION 6 0.0001
404 PANCREATITIS 3 0.0001
405 GOUT 1 0.0001
406 DRUG EFFECT DECREASED 3 0.0001
407 GASTROENTERITIS VIRAL 1 0.0001
408 LEUKOCYTOSIS 1 0.0001
409 CRYING 2 0.0001
410 RESTLESS LEGS SYNDROME 1 0.0001
411 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
412 EYE SWELLING 2 0.0001
413 URTICARIA 9 0.0001
414 MIDDLE INSOMNIA 1 0.0001
415 HYPOAESTHESIA 8 0.0001
416 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
417 EYE PAIN 3 0.0001
418 RASH 23 0.0001
419 FOOT FRACTURE 1 0.0001
420 BLOOD URINE PRESENT 1 0.0001
421 PULMONARY EMBOLISM 5 0.0001
422 FEELING JITTERY 1 0.0001
423 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
424 POST PROCEDURAL COMPLICATION 1 0.0001
425 LOWER LIMB FRACTURE 1 0.0001
426 GLAUCOMA 1 0.0001
427 EAR PAIN 1 0.0001
428 ATRIAL FIBRILLATION 5 0.0001
429 DYSPHONIA 3 0.0001
430 KIDNEY INFECTION 1 0.0001
431 BLOOD PRESSURE ABNORMAL 1 0.0001
432 UPPER LIMB FRACTURE 1 0.0001
433 SPINAL FRACTURE 1 0.0000
434 THROMBOSIS 4 0.0000
435 JOINT SWELLING 6 0.0000
436 PRODUCT ADMINISTRATION ERROR 1 0.0000
437 INJURY ASSOCIATED WITH DEVICE 1 0.0000
438 FEELING HOT 3 0.0000
439 INJECTION SITE WARMTH 1 0.0000
440 RENAL IMPAIRMENT 4 0.0000
441 MOUTH ULCERATION 1 0.0000
442 OSTEOARTHRITIS 2 0.0000
443 RETCHING 1 0.0000
444 IMPAIRED WORK ABILITY 1 0.0000
445 IRRITABLE BOWEL SYNDROME 1 0.0000
446 HYPOACUSIS 2 0.0000
447 FAECES DISCOLOURED 1 0.0000
448 SWELLING FACE 3 0.0000
449 CONDITION AGGRAVATED 14 0.0000
450 MENTAL DISORDER 2 0.0000
451 APPLICATION SITE PAIN 1 0.0000
452 INFUSION RELATED REACTION 3 0.0000
453 RASH MACULO-PAPULAR 1 0.0000
454 GASTROINTESTINAL DISORDER 4 0.0000
455 DEVICE ISSUE 4 0.0000
456 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
457 THROAT IRRITATION 2 0.0000
458 ADVERSE DRUG REACTION 4 0.0000
459 PANCREATITIS ACUTE 1 0.0000
460 CHROMATURIA 1 0.0000
461 PRODUCT DOSE OMISSION ISSUE 13 0.0000
462 APPLICATION SITE PRURITUS 1 0.0000
463 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
464 SKIN DISCOLOURATION 2 0.0000
465 NASOPHARYNGITIS 8 0.0000
466 MUSCLE TWITCHING 1 0.0000
467 SEIZURE 5 0.0000
468 PERICARDIAL EFFUSION 1 0.0000
469 CHEST PAIN 8 0.0000
470 RENAL DISORDER 2 0.0000
471 COUGH 12 0.0000
472 PALPITATIONS 5 0.0000
473 ARRHYTHMIA 2 0.0000
474 OCULAR HYPERAEMIA 2 0.0000
475 FALL 14 0.0000
476 PRODUCT PRESCRIBING ERROR 1 0.0000
477 PRODUCTIVE COUGH 2 0.0000
478 MULTIPLE SCLEROSIS 2 0.0000
479 BLOOD GLUCOSE DECREASED 2 0.0000
480 LOCALISED INFECTION 1 0.0000
481 INTERSTITIAL LUNG DISEASE 2 0.0000
482 FIBROMYALGIA 1 0.0000
483 NEURALGIA 1 0.0000
484 DYSPEPSIA 4 0.0000
485 PNEUMONIA 13 0.0000
486 FATIGUE 31 0.0000
487 CHRONIC KIDNEY DISEASE 3 0.0000
488 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
489 HAEMATEMESIS 1 0.0000
490 WEIGHT DECREASED 11 0.0000
491 LOSS OF CONSCIOUSNESS 5 0.0000
492 HAEMOGLOBIN DECREASED 4 0.0000
493 ERECTILE DYSFUNCTION 1 0.0000
494 INFLAMMATION 2 0.0000
495 RASH GENERALISED 1 0.0000
496 RESPIRATORY TRACT INFECTION 1 0.0000
497 DEAFNESS 1 0.0000
498 APPLICATION SITE ERYTHEMA 1 0.0000
499 ARTHRITIS 3 0.0000
500 INJECTION SITE BRUISING 3 0.0000
501 INJECTION SITE HAEMORRHAGE 3 0.0000
502 BREAST CANCER FEMALE 1 0.0000
503 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
504 BLOOD BILIRUBIN INCREASED 1 0.0000
505 CONSTIPATION 8 0.0000
506 NAUSEA 29 0.0000
507 TREATMENT NONCOMPLIANCE 2 0.0000
508 SKIN LESION 1 0.0000
509 PRURITUS 14 0.0000
510 VISION BLURRED 5 0.0000
511 ABNORMAL DREAMS 1 0.0000
512 ANAPHYLACTIC REACTION 2 0.0000
513 DIVERTICULITIS 1 0.0000
514 NECK PAIN 2 0.0000
515 DEMENTIA 1 0.0000
516 INTENTIONAL DOSE OMISSION 1 0.0000
517 HYPERSOMNIA 1 0.0000
518 MYOCARDIAL INFARCTION 6 0.0000
519 OFF LABEL USE 30 0.0000
520 DYSSTASIA 1 0.0000
521 NASAL CONGESTION 2 0.0000
522 URINARY INCONTINENCE 1 0.0000
523 WHEEZING 2 0.0000
524 DYSPNOEA 19 0.0000
525 HEADACHE 21 0.0000
526 DRUG INEFFECTIVE 44 0.0000
527 APHASIA 1 0.0000
528 LACRIMATION INCREASED 1 0.0000
529 ILL-DEFINED DISORDER 2 0.0000
530 GYNAECOMASTIA 1 0.0000
531 LIMB DISCOMFORT 1 0.0000
532 NERVOUS SYSTEM DISORDER 1 0.0000
533 SWOLLEN TONGUE 1 0.0000
534 BONE DENSITY DECREASED 1 0.0000
535 PYREXIA 11 0.0000
536 DYSPHAGIA 3 0.0000
537 HYPERHIDROSIS 4 0.0000
538 NIGHT SWEATS 1 0.0000
539 CONFUSIONAL STATE 5 0.0000
540 PAIN 19 0.0000
541 DEEP VEIN THROMBOSIS 2 0.0000
542 PSORIASIS 4 0.0000
543 CHOLELITHIASIS 1 0.0000
544 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
545 DECREASED APPETITE 7 0.0000
546 BACK PAIN 7 0.0000
547 RENAL FAILURE 4 0.0000
548 VIRAL INFECTION 1 0.0000
549 SYNCOPE 3 0.0000
550 SKIN DISORDER 1 0.0000
551 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
552 MYALGIA 5 0.0000
553 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
554 HEPATIC ENZYME INCREASED 2 0.0000
555 URINARY TRACT INFECTION 5 0.0000
556 HAEMATURIA 1 0.0000
557 ERYTHEMA 6 0.0000
558 GASTRIC DISORDER 1 0.0000
559 NIGHTMARE 1 0.0000
560 COVID-19 5 0.0000
561 HEART RATE DECREASED 1 0.0000
562 LYMPHADENOPATHY 1 0.0000
563 SKIN BURNING SENSATION 2 0.0000
564 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
565 INFECTION 4 0.0000
566 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
567 MALAISE 12 0.0000
568 ACCIDENTAL OVERDOSE 1 0.0000
569 RESTLESSNESS 1 0.0000
570 INJECTION SITE MASS 1 0.0000
571 HYPERSENSITIVITY 5 0.0000
572 DYSGEUSIA 2 0.0000
573 WEIGHT INCREASED 6 0.0000
574 PRODUCT USE ISSUE 5 0.0000
575 DYSPNOEA EXERTIONAL 1 0.0000
576 ASTHMA 3 0.0000
577 HALLUCINATION 2 0.0000
578 HOT FLUSH 2 0.0000
579 INTESTINAL OBSTRUCTION 1 0.0000
580 RHEUMATOID ARTHRITIS 3 0.0000
581 MUSCULAR WEAKNESS 3 0.0000
582 DIABETES MELLITUS 2 0.0000
583 BLOOD PRESSURE INCREASED 4 0.0000
584 INJECTION SITE SWELLING 2 0.0000
585 PLASMA CELL MYELOMA 1 0.0000
586 CHILLS 3 0.0000
587 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
588 ABNORMAL BEHAVIOUR 1 0.0000
589 FEELING ABNORMAL 6 0.0000
590 ABORTION SPONTANEOUS 1 0.0000
591 CARDIAC FAILURE CONGESTIVE 2 0.0000
592 DEVICE BREAKAGE 1 0.0000
593 DYSKINESIA 1 0.0000
594 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
595 ABDOMINAL PAIN UPPER 5 0.0000
596 POLLAKIURIA 1 0.0000
597 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
598 ABDOMINAL DISCOMFORT 4 0.0000
599 RENAL FAILURE ACUTE 1 0.0000
600 VOMITING 11 0.0000
601 PRODUCT STORAGE ERROR 2 0.0000
602 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
603 DEHYDRATION 3 0.0000
604 DRY SKIN 3 0.0000
605 PULMONARY OEDEMA 1 0.0000
606 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
607 PRODUCT QUALITY ISSUE 3 0.0000
608 NO ADVERSE EVENT 4 0.0000
609 DEPRESSION 5 0.0000
610 MEMORY IMPAIRMENT 3 0.0000
611 TINNITUS 1 0.0000
612 ADVERSE EVENT 2 0.0000
613 BLOOD CHOLESTEROL INCREASED 1 0.0000
614 CARDIAC DISORDER 2 0.0000
615 ANXIETY 6 0.0000
616 NEUROPATHY PERIPHERAL 2 0.0000
617 MIGRAINE 2 0.0000
618 COLORECTAL CANCER 1 0.0000
619 RASH ERYTHEMATOUS 1 0.0000
620 GAIT DISTURBANCE 4 0.0000
621 LUNG DISORDER 1 0.0000
622 LEUKOPENIA 1 0.0000
623 CELLULITIS 1 0.0000
624 PERIPHERAL SWELLING 3 0.0000
625 NERVOUSNESS 1 0.0000
626 ECZEMA 1 0.0000
627 MUSCULOSKELETAL PAIN 1 0.0000
628 SPEECH DISORDER 1 0.0000
629 BRADYCARDIA 1 0.0000
630 DISTURBANCE IN ATTENTION 1 0.0000
631 TREMOR 3 0.0000
632 DIZZINESS 9 0.0000
633 BLISTER 1 0.0000
634 OXYGEN SATURATION DECREASED 1 0.0000
635 CONVULSION 1 0.0000
636 BONE PAIN 1 0.0000
637 DISEASE PROGRESSION 2 0.0000
638 STOMATITIS 1 0.0000
639 VERTIGO 1 0.0000
640 DISCOMFORT 1 0.0000
641 VISUAL IMPAIRMENT 2 0.0000
642 ANAEMIA 3 0.0000
643 AMNESIA 1 0.0000
644 PRODUCT DOSE OMISSION 1 0.0000
645 BLOOD PRESSURE DECREASED 1 0.0000
646 NEOPLASM MALIGNANT 1 0.0000
647 DEVICE MALFUNCTION 1 0.0000
648 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
649 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
650 THERAPY INTERRUPTED 1 0.0000
651 RESPIRATORY FAILURE 1 0.0000
652 UNDERDOSE 1 0.0000
653 BRONCHITIS 1 0.0000
654 EPISTAXIS 1 0.0000
655 ACNE 1 0.0000
656 ACUTE KIDNEY INJURY 2 0.0000
657 DRUG INTERACTION 2 0.0000
658 PROSTATE CANCER 1 0.0000
659 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
660 TOXICITY TO VARIOUS AGENTS 2 0.0000
661 SKIN EXFOLIATION 1 0.0000
662 MUSCULOSKELETAL STIFFNESS 1 0.0000
663 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
664 SUICIDAL IDEATION 1 0.0000
665 SWELLING 1 0.0000
666 ALOPECIA 2 0.0000
667 HYPOTENSION 2 0.0000
668 ILLNESS 1 0.0000
669 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
670 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
671 THROMBOCYTOPENIA 1 0.0000
672 EMOTIONAL DISTRESS 1 0.0000
673 NEUTROPENIA 1 0.0000
674 DEATH 6 0.0000
675 HOSPITALISATION 1 0.0000
676 DRUG DEPENDENCE 1 0.0000